Supplier Type
- Manufacturer
- custom synthesis
- Trader
- Reagent
- contract manufacturer
Supplier Region
- Bangalore(2)
- New Delhi(2)
- Mumbai(35)
- Ahmedabad(10)
- Maharashtra(15)
- Andhra Pradesh(2)
- Beijing(1)
- Hyderabad(23)
- Gujarat(19)
- Telangana(2)
- Pune(2)
- Vadodara(5)
- Haryana(4)
- Karnataka(8)
- Uttar Pradesh(6)
- Tamil Nadu(1)
- Delhi(7)
- Kolkata(2)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- More than 98%
- more than 95%
- more than 90%
- Mixture Not applicable
- MINIMUM 99%
- Min. 99.0%
- Min 98 %
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.98%
- 99.95%
- 99.93%
- 99.91%
- 99.90%
- 99.88%
- 99.86%
- 99.85%
- 99.84%
- 99.81%
- 99.73%
- 99.70%
- 99.68%
- 99.61%
- 99.47%
- 99.42%
- 99.40%
- 99.34%
- 99.30%
- 99.29%
- 99.28%
- 99.27%
- 99.21%
- 99.10%
- 99.0%
- 99% min
- > 99%
- >99%
- 99%
- 99
- 98=%
- 98+
- 98.91%
- 98.88%
- 98.70%
- 98.65%
- 98.60%
- 98.58%
- 98.54%
- 98.53%
- 98.50%
- 98.5
- 98.20%
- 98.18%
- 98.12%
- 98.08%
- 98.00%
- 98% Min.
- 98% Min
- 98%
- >98%
- 97-99%
- 97.61%
- 97.57%
- > 97.5 %
- 97.00%
- 97% min
- 97%
- >97%
- 97 %
- 96.80%
- 96.64%
- 96.5 - 103.5 %
- 96.40%
- 96.39%
- 96%
- 95-98%
- 95.16%
- 95.00%
- >95%
- 95%
- 95 %
- 94.34%
- 94.25%
- 94.00%
- 93.21%
- 92-95%
- 92.60%
- >92%
- 91.87%
- 90%-95%
- >90%
- 90%
- 90 % Above
- 84.49%
- 65%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- 0.04%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0MG TO GRAM
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 11Between 1 gm to 1 MT (As per availability)
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Pilocarpine impurity B & C mixture
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
-
CONDURITOL B EPOXIDE
6090-95-5
-
Montelukast Acyl-b-D-glucuronide
188717-17-1
-
10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
3159-07-7
-
Bekanamycin
4696-76-8
-
6-HYDROXY-2,4,5-TRIAMINOPYRIMIDINE SULFATE
39267-74-8
-
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5
-
Cyclopropylacetylene
6746-94-7
-
1,2,4-Triazole
288-88-0
Pilocarpine impurity B & C mixture
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
Conduritol b epoxide 6090-95-5
Dibenzo[b,f][1,4]-thiazepin-11(10H)-one 3159-07-7
Kanamycin B 4696-76-8
6-Hydroxy-2,4,5-triaminopyrimidine sulfate 39267-74-8
Carbon black 1333-86-4
Ciprofloxacin hydrochloride 93107-08-5
4,5,6,7-Tetrahydrothieno[3,2,c]pyridine hydrochloride 28783-41-7
Phloxine B 18472-87-2